BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12070663)

  • 1. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
    Haslbeck KM; Schleicher ED; Friess U; Kirchner A; Neundörfer B; Heuss D
    Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?
    Haslbeck KM; Neundörfer B; Schlötzer-Schrehardtt U; Bierhaus A; Schleicher E; Pauli E; Haslbeck M; Hecht M; Nawroth P; Heuss D
    Neurol Res; 2007 Jan; 29(1):103-10. PubMed ID: 17427284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy.
    Haslbeck KM; Bierhaus A; Erwin S; Kirchner A; Nawroth P; Schlötzer U; Neundörfer B; Heuss D
    Muscle Nerve; 2004 Jun; 29(6):853-60. PubMed ID: 15170618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
    Haslbeck KM; Schleicher E; Bierhaus A; Nawroth P; Haslbeck M; Neundörfer B; Heuss D
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):288-91. PubMed ID: 15926115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease.
    Palumbo C; Massa R; Panico MB; Di Muzio A; Sinibaldi P; Bernardi G; Modesti A
    Acta Neuropathol; 2002 Sep; 104(3):287-96. PubMed ID: 12172915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy.
    Broglio L; Erne B; Tolnay M; Schaeren-Wiemers N; Fuhr P; Steck AJ; Renaud S
    Muscle Nerve; 2008 Oct; 38(4):1272-9. PubMed ID: 18816612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies.
    Lindenlaub T; Sommer C
    Acta Neuropathol; 2003 Jun; 105(6):593-602. PubMed ID: 12734666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
    Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy.
    Mazzeo A; Aguennouz M; Messina C; Vita G
    Arch Neurol; 2004 Jul; 61(7):1097-102. PubMed ID: 15262741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
    Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
    Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
    Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyneuropathies in teenagers: a clinicopathological study of 45 cases.
    Kararizou E; Karandreas N; Davaki P; Davou R; Vassilopoulos D
    Neuromuscul Disord; 2006 May; 16(5):304-7. PubMed ID: 16616844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation.
    Baumann M; Caron M; Schmaderer C; Schulte C; Viklicky O; von Weyhern CW; Lutz J; Heemann U
    Transplantation; 2008 Jul; 86(2):330-5. PubMed ID: 18645498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies.
    Renaud S; Erne B; Fuhr P; Said G; Lacroix C; Steck AJ; Leppert D
    Acta Neuropathol; 2003 Jan; 105(1):37-42. PubMed ID: 12471459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy.
    Misur I; Zarković K; Barada A; Batelja L; Milicević Z; Turk Z
    Acta Diabetol; 2004 Dec; 41(4):158-66. PubMed ID: 15660198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of CIDP in patients with diabetes or CMT1.
    Latov N
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy.
    Van Rhijn I; Van den Berg LH; Bosboom WM; Otten HG; Logtenberg T
    Brain; 2000 Oct; 123 ( Pt 10)():2020-9. PubMed ID: 11004119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy.
    Boukhris S; Magy L; Kabore R; Mabrouk T; Li Y; Sindou P; Tabaraud F; Vallat JM
    Neurophysiol Clin; 2004 Apr; 34(2):71-9. PubMed ID: 15130553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.